|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the SNY 6-K filed Jun 1, 2005. ANNUAL GENERAL MEETING
The Annual General Meeting of sanofi-aventis shareholders was held on May 31, 2005. The General Meeting approved the financial statements for the year ended December 31, 2004. Also approved was the distribution of a net dividend of 1.20 euro per share, a 17.6% increase over the previous year. The dividend will be paid out on June 7, 2005. The General Meeting has reappointed PricewaterhouseCoopers Audit to serve as statutory auditors for a period of six years expiring at the end of the General Meeting held to approve the financial statements for the year ending December 31, 2010, with Mr. Pierre Coll reappointed Deputy Statutory Auditor for the same period. The Board of Directors of sanofi-aventis in its meeting held after the General Meeting has resolved to cancel shares representing 1.15% of sanofi-aventis share capital, held by the Group in treasury. Following this cancellation, the share capital of sanofi-aventis amounts to €2,791,376,578 divided into 1,395,688,289 shares, each having a nominal value of €2. During the General Meeting, Chairman and CEO Jean-François Dehecq confirmed the rapid and efficient integration of the new Group, in line with its strategy of strong, sustainable and profitable growth. Mr. Dehecq also stated that first quarter results supported the goals for 2005.
|
| |||||||
